Advertisement

Topics

CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES

15:09 EST 2 Dec 2016 | Takeda

Osaka, Japan and Cambridge, MA; Dec. 2, 2016 - Takeda Pharmaceutical Company Limited (TSE: 4502) and Lightstone Ventures today announced the launch of Cerevance, a neuroscience company focused on discovering and developing novel therapeutics for neurological and psychiatric disorders. The compa

Original Article: CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES

NEXT ARTICLE

More From BioPortfolio on "CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES"

Quick Search
Advertisement